NORDの企業概要
日中の時刻はETです。市場データは遅延する場合があります。
企業プロフィール
会社ウェブサイトNordicus Partners Corporation functions as a publicly traded entity that acts as both a business accelerator and a holding company, specifically supporting Nordic life sciences firms operating within the United States. A central focus for the company involves advancing oral healthcare through the development of new medicines. In addition to its core operations, Nordicus offers an array of corporate finance and advisory services. These include aiding in business and market expansion, formulating strategic growth plans, identifying and acquiring talent, fostering key partnerships, facilitating capital raising efforts, and orchestrating company acquisitions or sales. The organization, which was established in 1993 and is headquartered in Beverly Hills, California, rebranded as Nordicus Partners Corporation in May 2023, having previously been known as EKIMAS Corporation.
- 業界
- Biotechnology
- セクター
- Healthcare
- 本社
- US
- 最高経営責任者(CEO)
- Henrik Rouf
- 上場以来
- 1996年6月12日
- 従業員
- 15
市場での位置
日中レンジ
現在 $2.80
52週レンジ
現在 $2.80
- 始値
- $2.50
- 前日終値
- $2.93
- 出来高
- 4716
- 0.73× 平均
- 平均出来高
- 6441
- 1日平均出来高
- 時価総額
- 5444.29万 USD
- ベータ
- -0.7
- 市場参照 1
- 50日平均
- $3.6086
- 平均以下(-22.41%)
- 200日平均
- $3.5019
- 平均以下(-20.04%)








